Clinical Trial Update: HIV Maintenance Therapy With T-20 During HAART Interruption [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 clinical trial of HIV maintenance therapy with T-20 (enfuvirtide) during interruptions of HAART.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• T-20 (enfuvirtide) (enfuvirtide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection | Phase 2 | Status: COMPLETED